Seagate Technology (STX) official guidance

For fiscal 2027, we continue to expect CapEx investment will remain within our target range of 4%-6% of revenue as we support the ongoing transition to HAMR technology.

Non-GAAP EPS is expected to be $9.20 ± $0.20 based on a tax rate of about 16% and non-GAAP diluted share count of 233 million shares.

Non-GAAP EPS is expected to be $9.20 ± $0.20 based on a tax rate of about 16% and non-GAAP diluted share count of 233 million shares.

Non-GAAP EPS is expected to be $9.20 ± $0.20 based on a tax rate of about 16% and non-GAAP diluted share count of 233 million shares.

We expect cash generation to further improve throughout fiscal 2027, supported by sustained demand, operational efficiencies and CapEx discipline.

Non-GAAP operating expenses are expected to remain flat at approximately $300 million.

We are suggesting something that is between 50% and 55%.

Following the debt reduction we completed early in October, we anticipate other income and expenses to decrease further in the December quarter to approximately $25 million, benefiting from the lower interest expense.

We expect December quarter revenue to be in a range of $4.8 billion ± $100 million, which represents a 17% year-over-year improvement at the midpoint.

Our September quarter results and December quarter outlook reinforce our expectation for annual revenue growth to meaningfully outpace fiscal 2026.

We exited the September quarter with $4.4 billion remaining on our existing share repurchase authorization and expect to significantly increase share repurchases starting calendar 2027.

Non-GAAP EPS is expected to be $7.30 ± $0.20, based on a tax rate of about 16% and non-GAAP diluted share count of 231 million shares, including estimated dilution from our 2028 convertible notes of approximately 2 million shares.

Non-GAAP EPS is expected to be $7.30 ± $0.20, based on a tax rate of about 16% and non-GAAP diluted share count of 231 million shares, including estimated dilution from our 2028 convertible notes of approximately 2 million shares.

Non-GAAP EPS is expected to be $7.30 ± $0.20, based on a tax rate of about 16% and non-GAAP diluted share count of 231 million shares, including estimated dilution from our 2028 convertible notes of approximately 2 million shares.

Non-GAAP operating expenses are expected to be approximately $300 million.

Based on the midpoint of our revenue guidance, non-GAAP operating margin is expected to be around 50%.

In the June quarter, other income and expenses were $58 million, and we project OIE to decrease further in the September quarter to approximately $45 million, reflecting the benefit from lower interest expense as we continue to reduce our outstanding debt balance.

We expect September quarter revenue to be in a range of $4.1 billion ± $100 million, which represents a 56% year-over-year improvement at the midpoint.

We expect capital expenditure for fiscal year 2026 to be inside our target range of 4%-6% of revenue, with investment aimed at the ongoing transition and ramp of HAMR-based products.

Non-GAAP EPS is expected to be $5.00 ± $0.20 based on a tax rate of about 16% and non-GAAP diluted share count of 231 million shares, including estimated dilution from our 2028 convertible notes of approximately 3 million shares.